BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22080892)

  • 1. Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang HS; Yoon C; Myung SK; Park SM
    Int J Gynecol Cancer; 2011 Dec; 21(9):1525-32. PubMed ID: 22080892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis.
    Bae HS; Kim HJ; Hong JH; Lee JK; Lee NW; Song JY
    J Ovarian Res; 2014; 7():41. PubMed ID: 24834130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.
    Gao J; Yang X; Zhang Y
    Jpn J Clin Oncol; 2015 Jan; 45(1):49-60. PubMed ID: 25387732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
    Yang Z; Gu JH; Guo CS; Li XH; Yang WC
    Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis.
    Rota M; Pasquali E; Scotti L; Pelucchi C; Tramacere I; Islami F; Negri E; Boffetta P; Bellocco R; Corrao G; La Vecchia C; Bagnardi V
    Gynecol Oncol; 2012 Jun; 125(3):758-63. PubMed ID: 22449732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: a meta-analysis of observational studies.
    Lee JY; Myung SK; Song YS
    Gynecol Oncol; 2013 Jun; 129(3):613-9. PubMed ID: 23422504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
    Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
    JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic risk factors and mechanisms of disease in epithelial ovarian cancer: A review.
    Craig ER; Londoño AI; Norian LA; Arend RC
    Gynecol Oncol; 2016 Dec; 143(3):674-683. PubMed ID: 27751590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis.
    Luo Y; Kim HS; Kim M; Lee M; Song YS
    J Gynecol Oncol; 2017 May; 28(3):e36. PubMed ID: 28382799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Height, weight, BMI and ovarian cancer survival.
    Kotsopoulos J; Moody JR; Fan I; Rosen B; Risch HA; McLaughlin JR; Sun P; Narod SA
    Gynecol Oncol; 2012 Oct; 127(1):83-7. PubMed ID: 22713293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies.
    Li DP; Du C; Zhang ZM; Li GX; Yu ZF; Wang X; Li PF; Cheng C; Liu YP; Zhao YS
    Asian Pac J Cancer Prev; 2014; 15(12):4829-37. PubMed ID: 24998548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of geographic variations in treatment on outcomes in ovarian cancer.
    Dehaeck U; McGahan CE; Santos JL; Carey MS; Swenerton KD; Kwon JS
    Int J Gynecol Cancer; 2013 Feb; 23(2):282-7. PubMed ID: 23295939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis.
    Jia H; Zhang Q; Liu F; Zhou D
    Arch Gynecol Obstet; 2017 Mar; 295(3):689-696. PubMed ID: 27995372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: a metaanalysis of four prospective randomised phase III trials with 5114 patients.
    Sehouli J; Fotopoulou C; Erol E; Richter R; Reuss A; Mahner S; Lauraine EP; Kristensen G; Herrstedt J; du Bois A; Pfisterer J
    Eur J Cancer; 2015 May; 51(7):825-32. PubMed ID: 25771433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort.
    Weiderpass E; Sandin S; Inoue M; Shimazu T; Iwasaki M; Sasazuki S; Sawada N; Yamaji T; Tsugane S
    Int J Oncol; 2012 Jan; 40(1):21-30. PubMed ID: 21904774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis.
    Olsen CM; Green AC; Whiteman DC; Sadeghi S; Kolahdooz F; Webb PM
    Eur J Cancer; 2007 Mar; 43(4):690-709. PubMed ID: 17223544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between overweight, obesity and ovarian cancer: a meta-analysis.
    Liu Z; Zhang TT; Zhao JJ; Qi SF; Du P; Liu DW; Tian QB
    Jpn J Clin Oncol; 2015 Dec; 45(12):1107-15. PubMed ID: 26491203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and ovarian cancer survival: a systematic review and meta-analysis.
    Protani MM; Nagle CM; Webb PM
    Cancer Prev Res (Phila); 2012 Jul; 5(7):901-10. PubMed ID: 22609763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, mortality, and survival trends of ovarian cancer in Hong Kong, 1997 to 2006: a population-based study.
    Wong KH; Mang OW; Au KH; Law SC
    Hong Kong Med J; 2012 Dec; 18(6):466-74. PubMed ID: 23223646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.